Zuzana Zděblová Čermáková

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Squamous Cell Carcinoma

Prognostic Factors

Radiation Therapy

Chronic Kidney Disease

Top Venues

Medicina (Kaunas, Lithuania)

Radiation oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Zuzana Zděblová Čermáková, Pavel Hurník, David Konvalinka, Jan Štembírek, Tereza Paračková, Kamila Resová, Jakub Cvek, Tomáš Blažek, Lukas Knybel, Martin Formánek, Mariam Gachechiladze, Markus Joerger, Alex Soltermann, Jozef Škarda, Oldřich Motyka, Jana Janoutová
HPV and RAD51 as Prognostic Factors for Survival in Inoperable Oral and Oropharyngeal Cancer in Patients Unfit for Chemotherapy Treated with Hyperfractionated Radiotherapy. Medicina (Kaunas, Lithuania) 59 (2) (2023)
Zuzana Zděblová Čermáková, Pavel Hurník, David Konvalinka, Jan Štembírek, Tereza Paračková, Kamila Resová, Jakub Cvek, Tomáš Blažek, Lukas Knybel, Martin Formánek, Mariam Gachechiladze, Markus Joerger, Alex Soltermann, Jozef Škarda, Oldřich Motyka, Jana Janoutová
HPV and RAD51 as Prognostic Factors for Survival in Inoperable Oral and Oropharyngeal Cancer in Patients Unfit for Chemotherapy Treated with Hyperfractionated Radiotherapy. Medicina (Kaunas, Lithuania) 59 (2) (2023)
Zuzana Zděblová Čermáková, Pavel Hurník, David Konvalinka, Jan Štembírek, Tereza Paračková, Kamila Resová, Jakub Cvek, Tomáš Blažek, Lukas Knybel, Martin Formánek, Mariam Gachechiladze, Markus Joerger, Alex Soltermann, Jozef Škarda, Oldřich Motyka, Jana Janoutová
HPV and RAD51 as Prognostic Factors for Survival in Inoperable Oral and Oropharyngeal Cancer in Patients Unfit for Chemotherapy Treated with Hyperfractionated Radiotherapy. Medicina (Kaunas, Lithuania) 59 (2) (2023)
Tomas Blazek, Zuzana Zděblová Čermáková, Lukas Knybel, Pavel Hurník, Jan Štembírek, Kamila Resová, Tereza Paračková, Martin Formánek, Jakub Cvek, Renata Soumarová
Dose escalation in advanced floor of the mouth cancer: a pilot study using a combination of IMRT and stereotactic boost. Radiation oncology (London, England) 16 (1) (2021)